Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Carcinogenesis

• Publication date

  2009-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/carcin/bgp015PMID 19136474PMCID PMC2650796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death.

  2009cited by this paper
• Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling.

  2009cited by this paper
• Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer

  2008cited by this paper
• Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid.

  2008cited by this paper
• The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents.

  2008cited by this paper
• NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.

  2008cited by this paper
• The novel phenylester anticancer compounds: Study of a derivative of aspirin (phoshoaspirin).

  2008cited by this paper
• The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia

  2007cited by this paper
• MAP kinases and the control of nuclear events

  2007cited by this paper
• Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy

  2007cited by this paper
• Oxidative stress and cancer: have we moved forward?

  2007cited by this paper
• Cross‐talks between cyclooxygenase‐2 and tumor suppressor protein p53: Balancing life and death during inflammatory stress and carcinogenesis

  2007influential reference
• NF-κB, inflammation and pancreatic carcinogenesis: NF-κB as a chemoprevention target (Review)

  2006cited by this paper
• NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).

  2006cited by this paper
• Nitric Oxide-Donating Aspirin Inhibits Colon Cancer Cell Growth via Mitogen-Activated Protein Kinase Activation

  2006cited by this paper
• The NF-kappaB-mediated control of ROS and JNK signaling.

  2006cited by this paper
• NF-κB: linking inflammation and immunity to cancer development and progression

  2005cited by this paper
• Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress.

  2005cited by this paper
• NF-kappaB: linking inflammation and immunity to cancer development and progression.

  2005cited by this paper
• Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies.

  2005cited by this paper
• Mechanisms of Disease: PI3K/AKT Signaling in Gastrointestinal Cancers

  2005cited by this paper
• Positional Isomerism Markedly Affects the Growth Inhibition of Colon Cancer Cells by Nitric Oxide-Donating Aspirin in Vitro and in Vivo

  2005cited by this paper
• Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration

  2004cited by this paper
• Targeting signal transduction pathways by chemopreventive agents.

  2004cited by this paper
• Apoptosis and colorectal cancer

  2004cited by this paper
• The role of oxidative stress in carcinogenesis.

  2004cited by this paper
• Epicatechin, catechin, and dimeric procyanidins inhibit PMA‐induced NF‐κB activation at multiple steps in Jurkat T cells

  2004cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas.

  2003cited by this paper
• Epidemiology of non-steroidal anti-inflammatory drugs and cancer.

  2003cited by this paper
• Targeting JNK for therapeutic benefit: from junk to gold?

  2003cited by this paper
• The Role of NSAIDs in the Prevention of Colon Cancer

  2002cited by this paper
• Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.

  2001cited by this paper
• Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

  2001cited by this paper
• Mammalian MAP kinase signalling cascades

  2001cited by this paper
• Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress.

  1992cited by this paper
• Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy.

  1991cited by this paper
• Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

  1979cited by this paper
• Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.

  1969cited by this paper

• Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances

  2025cites this paper
• NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future.

  2021cites this paper
• New Formulation of a Methylseleno-Aspirin Analog with Anticancer Activity Towards Colon Cancer

  2020cites this paper
• Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine.

  2019cites this paper
• Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.

  2019cites this paper
• A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras

  2018cites this paper
• Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.

  2018cites this paper
• Nonsteroidal Anti‐Inflammatory Therapy: A Journey Toward Safety

  2017cites this paper
• Synthesis, crystal structure, DNA interaction and anticancer evaluation of pyruvic acid derived hydrazone and its transition metal complexes

  2017cites this paper
• Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice

  2016cites this paper
• Prodrugs Bioactivated to Quinones Target NF-κB and Multiple Protein Networks: Identification of the Quinonome.

  2016cites this paper
• Cell and Molecular Processes in Cancer Metastasis Lamin A / C deficiency reduces circulating tumor cell resistance to fluid shear stress

  2015cites this paper
• Lamin A/C deficiency reduces circulating tumor cell resistance to fluid shear stress.

  2015cites this paper
• Identification of aspirin analogues that repress NF-κB signalling and demonstrate anti-proliferative activity towards colorectal cancer in vitro and in vivo.

  2014cites this paper
• Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect

  2014cites this paper
• Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress

  2014cites this paper
• The Proapoptotic Effect of Traditional and Novel Nonsteroidal Anti-Inflammatory Drugs in Mammalian and Yeast Cells

  2013influential citation
• Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice

  2013influential citation
• p38 MAPK: A dual role in hepatocyte proliferation through reactive oxygen species

  2013cites this paper
• Synthesis and Antibacterial Activity of Acetoxybenzoyl Thioureas with Aryl and Amino Acid Side Chains

  2012cites this paper
• Carboxylesterases 1 and 2 Hydrolyze Phospho-Nonsteroidal Anti-Inflammatory Drugs: Relevance to Their Pharmacological Activity

  2012cites this paper
• Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical Review

  2012cites this paper
• The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse

  2012cites this paper
• Structure-activity relationship study of novel anticancer aspirin-based compounds.

  2011cites this paper
• Oxidative Stress Mediates through Apoptosis the Anticancer Effect of Phospho-Nonsteroidal Anti-Inflammatory Drugs: Implications for the Role of Oxidative Stress in the Action of Anticancer Agents

  2011cites this paper
• The novel phospho‐non‐steroidal anti‐inflammatory drugs, OXT‐328, MDC‐22 and MDC‐917, inhibit adjuvant‐induced arthritis in rats

  2011cites this paper
• Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds.

  2011influential citation
• Therapeutics , Targets , and Chemical Biology ChemotherapeuticPropertiesofPhospho-Nonsteroidal Anti-In fl ammatory Drugs , a New Class of Anticancer Compounds

  2011cites this paper
• Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice.

  2010cites this paper
• NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates

  2010cites this paper
• Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo.

  2010cites this paper
• Nitric Oxide-Releasing Molecules for Cancer Therapy and Chemoprevention

  2010cites this paper
• Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect.

  2010cites this paper
• The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.

  2009cites this paper
• IN PRESS hospho-Sulindac ( OXT-328 ) , a Novel Sulindac Derivative , Is Safe and ffective in Colon Cancer Prevention in Mice

  year unknowncites this paper